| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atyr Pharma Inc (ATYR) has 4 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. ATYR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.50M | $641.4K | - | |
| Dir | 1.41M | $604.2K | - | |
| CFO | 412.5K | $176.4K | - | |
| Other | 412.5K | $176.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 11, 2016 | Schimmel Paul53 | Director | Buy | 32,659 | $3.57 | $116,534.78 | +8.1% | |
| Apr 8, 2016 | Schimmel Paul53 | Director | Buy | 85,000 | $3.22 | $273,649.00 | +82.9% | |
| Apr 7, 2016 | Schimmel Paul53 | Director | Buy | 40,000 | $3.19 | $127,584.00 | +63.9% | |
| Apr 6, 2016 | Schimmel Paul53 | Director | Buy | 25,000 | $3.20 | $80,000.00 | +66.5% | |
| Apr 5, 2016 | Schimmel Paul53 | Director | Buy | 25,000 | $3.52 | $88,117.50 | +198.9% | |
| Apr 5, 2016 | Mendlein John50 | CEO And Director | Buy | 2,500 | $3.52 | $8,800.00 | +1.0% | |
| Apr 5, 2016 | Mendlein John50 | CEO And Director | Buy | 2,500 | $3.55 | $8,875.00 | +1.0% | |
| May 12, 2015 | Flynn James E62 | 10% Owner, Possible Member Of 10% Group | Buy | 50,000 | $14.00 | $700,000.00 | +10.8% | |
| May 12, 2015 | Sofinnova Venture Partners Ix, L.P. | 10% Owner | Buy | 320,000 | $14.00 | $4,480,000.00 | +20.7% | |
| May 12, 2015 | Akkaraju Srinivas81 | Director, Former 10% Owner | Buy | 320,000 | $14.00 | $4,480,000.00 | +20.7% |